False negative results in the Roche assay for HDL-cholesterol

被引:9
|
作者
Bakker, AJ
机构
[1] Stichting Klin Chem Lab, Dept Clin Chem, NL-8901 BR Leeuwarden, Netherlands
[2] Med Ctr Leeuwarden, Dept Internal Med, Leeuwarden, Netherlands
关键词
D O I
10.1258/000456303322326533
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Measurement of HDL-cholesterol is important in the risk evaluation of cardiovascular disease. Recently, we encountered a 61-year-old man with a negative result for HDL-cholesterol using the Roche assay. Further analysis revealed that this patient had a monoclonal Ig type IgMkappa, with an electrophoresis-based concentration of 55.8 g/L, which apparently caused the negative result for HDL-cholesterol. Analysis of serum samples from other patients with monoclonal or polyclonal hypergammaglobulinaemia revealed that false negative results in the Roche assay for HDL-cholesterol may occur incidentally. Since negative results are detected easily in the laboratory, such patients do not pose a problem in daily practice. However, it is reasonable to suppose that false low results could also be caused by monoclonal as well as polyclonal Igs. Since such false low results remain undetected, vascular risk estimates consequently are altered and unnecessary treatment might be started.
引用
收藏
页码:572 / 575
页数:4
相关论文
共 50 条
  • [41] HDL-cholesterol and treatment pathway
    Bruckert, E.
    Ferrieres, J.
    Farnier, M.
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2011, 3 (04) : 273 - 279
  • [42] ACCURACY OF HDL-CHOLESTEROL DETERMINATION
    NIEDMANN, PD
    LUTHE, H
    WIELAND, H
    SCHAPER, G
    SEIDEL, D
    KLINISCHE WOCHENSCHRIFT, 1983, 61 (03): : 133 - 138
  • [43] Falsely low direct HDL-cholesterol results in a patient with dysbetalipoproteinemia
    Roberts, WL
    Leary, ET
    Lambert, TL
    Moulton, L
    Goetsch, JL
    CLINICAL CHEMISTRY, 2000, 46 (04) : 560 - 562
  • [44] The complexity of the role of HDL-cholesterol
    Brotons, Carlos
    Moral, Irene
    Vicuna, Johanna
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (02): : 78 - 79
  • [45] SERUM PSEUDOCHOLINESTERASE AND HDL-CHOLESTEROL
    PUHAKAINEN, E
    RYHANEN, R
    PENTTILA, I
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1980, 18 (10): : 684 - 684
  • [46] CIMETIDINE, RANITIDINE AND HDL-CHOLESTEROL
    WILSON, JA
    CRAIG, IF
    GASTROENTEROLOGY, 1985, 88 (05) : 1632 - 1632
  • [47] HDL-cholesterol in hypertension and diabetes
    McFarlane-Anderson, N
    Bennett, F
    Wilks, R
    Forrester, T
    Cruickshank, K
    FASEB JOURNAL, 1999, 13 (04): : A272 - A272
  • [48] CordyMax reduces serum oxidized LDL-cholesterol and increases HDL-cholesterol in humans with reduced HDL-cholesterol
    Zhu, JS
    Pei, Y
    Xu, ZB
    Wang, BE
    Rippe, J
    CIRCULATION, 2003, 108 (17) : 781 - 781
  • [49] Development and multicenter evaluation of a new HDL-cholesterol reagent on Roche/Hitachi and COBAS INTEGRA® systems
    Klima, H.
    Domke, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 586 - 586
  • [50] A NEGATIVE CORRELATION BETWEEN ERYTHROCYTE AGGREGATION VALUE AND HDL-CHOLESTEROL CONCENTRATION
    RUHENSTROTHBAUER, G
    MOSSMER, G
    OTTL, J
    KOENIGERICH, S
    HEINEMANN, G
    KLINISCHE WOCHENSCHRIFT, 1987, 65 (20): : 1012 - 1012